title: Etanercept: effectiveness and safety data of a retrospective study.
authors.forename: C
authors.initials: C
authors.lastname: Antoniou
authors.forename: T
authors.initials: T
authors.lastname: Vergou
authors.forename: C
authors.initials: C
authors.lastname: Dessinioti
authors.forename: A J
authors.initials: AJ
authors.lastname: Stratigos
authors.forename: G
authors.initials: G
authors.lastname: Avgerinou
authors.forename: P
authors.initials: P
authors.lastname: Stavropoulos
authors.forename: A
authors.initials: A
authors.lastname: Katsambas
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept